GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1201 - 1225** of **4050** in total

« First

‹ Prev

…

45

46

47

48

49

50

51

52

53

…

Next ›

Last »
Antibody	Patient	Onset (days) ▼	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU)
IgM	Patient 2	3	mild	G90223GH	413
IgM	Patient 2	3	mild	G90562PB	82
IgM	Patient 2	3	mild	G91237TK	68
IgM	Patient 2	3	mild	G91537AT	462
IgM	Patient 2	3	mild	G92022ML	436
IgM	Patient 2	3	mild	G92823JK	92
IgM	Patient 2	3	mild	G93351GM	541
IgM	Patient 2	3	mild	G94435QH	47
IgM	Patient 2	3	mild	G94576MN	327
IgM	Patient 2	3	mild	G96557TJ	119
IgM	Patient 2	3	mild	G96865DJ	138
IgM	Patient 2	3	mild	G96881BQ	45
IgM	Patient 2	3	mild	G98068PA	170
IgM	Patient 2	3	mild	G98240FC	446
IgM	Patient 2	3	mild	G99603GB	267
IgA	Patient 2	24	mild	G00048MO	329
IgA	Patient 2	24	mild	G00051MO	271
IgA	Patient 2	24	mild	G00052MO	321
IgA	Patient 2	24	mild	G00053MO	314
IgA	Patient 2	24	mild	G00054MO	243
IgA	Patient 2	24	mild	G00057MO	879
IgA	Patient 2	24	mild	G00065MO	291
IgA	Patient 2	24	mild	G00066MO	1190
IgA	Patient 2	24	mild	G00068MO	296
IgA	Patient 2	24	mild	G02557XE	274